KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Prevail Peptides: 11 Kovera certificates.
The lab's record shows 11 certificates printed for Prevail Peptides, analysed between 7 Apr 2026 and 7 May 2026, covering 9 products. Median HPLC purity is 99.90%. Kovera graded 11 as a pass and 0 as a fail.
11
certificates
99.90%
median purity
9
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 11 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 5 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
9 AS PRINTEDRetatrutide · 2Tirzepatide · 2BPC-157 · 1Epithalon · 1GHK-Cu · 1IGF-1 LR3 · 1MOTS-c · 1PT-141 · 1TB-500 (Thymosin B4) · 1
Every certificate
NEWEST FIRST · 11 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-D0ABA2 | Tirzepatide | PP042826-TZ10 | 99.916% | 105.8%10.58 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-AA69DC | Retatrutide | PP042826-RT20 | 99.871% | 115.5%23.11 of 20 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-7C8139 | Retatrutide | PP042826-RT10 | 99.969% | 94.8%9.48 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-706EF1 | PT-141 | PP042826-PT10 | 99.883% | 92.4%9.24 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4F7194 | MOTS-c | PP042826-MS10 | 99.927% | 107.2%10.72 of 10 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-476EBF | TB-500 (Thymosin B4) | PP042826-TB10 | 99.879% | 112.2%11.22 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-2EF9D4 | GHK-Cu | PP042826-CU100 | 99.888% | 108.1%108.11 of 100 mg | 7 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-1989C8 | Epithalon | PP042826-ET10 | 99.862% | 118.8%11.88 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0357E7 | BPC-157 | PP042826-BC10 | 99.912% | 115.2%11.52 of 10 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-0170FF | Tirzepatide | PP042826-TZ20 | 99.899% | 110.6%22.12 of 20 mg | 7 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-B97AFB | IGF-1 LR3 | PP033126-IGF1 | 99.977% | 106.0%1.06 of 1 mg | 7 Apr 2026 | PASS | Kovera ↗our verifier → |